
Introduction: Why Related Substances Analysis Is Critical
When making medicines, it’s important to make sure that no unwanted chemicals (called “related substances”) are left behind in the final drug product. These related substances could be leftover reactants, by-products, or degradation products. That’s why Related Substances Analysis in United States is a key part of meeting FDA rules for safety and quality.
At ResolveMass Laboratories Inc., we help pharma companies detect and measure these substances accurately using advanced tools like HPLC, LC-MS, and NMR. We offer full testing support to meet the strict standards set by FDA and ICH Q3A/B.
➡ More on our impurity profiling capabilities
🔬 Explore Our Related Substance Testing Services
What Are Related Substances?
These are any unwanted chemicals in a drug substance or product. They might come from:
- Impurities from raw materials
- Leftover reagents
- Process by-products
- Breakdown products (degradation)
Even in tiny amounts, some related substances can affect the drug’s safety. That’s why regulatory agencies require companies to identify, measure, and control them.
➡ More on our NMR structure elucidation services
Why Related Substances Analysis Matters for FDA and Health Canada
The FDA and Health Canada both want to see that your product is pure, safe, and stable over time. Related substances analysis is required during:
- IND, NDA, and ANDA filings
- Drug master file (DMF) submissions
- Stability studies
At ResolveMass, we offer Related Substances Analysis in United States and Canada using validated, compliant methods.
Step-by-Step Guide to Related Substances Testing
Step 1: Sample Preparation
We begin with a clean, careful sample prep to avoid contamination. This includes dissolving the sample in a suitable solvent, filtration, and dilution if needed.
Step 2: Analytical Method Selection
Depending on the nature of the compound, we use:
- HPLC for general impurity profiling
- LC-MS/MS for low-level and unknown impurities
- GC for volatile impurities
- NMR for structural confirmation (Explore NMR Services)
Step 3: Method Development and Optimization
We fine-tune the method using:
- Column type
- Mobile phase
- Flow rate
- Detector settings
Step 4: Method Validation
Validation is done as per ICH Q2(R1) guidelines and covers:
- Specificity
- Linearity
- Precision
- Accuracy
- Detection limits (LOD/LOQ)
Step 5: Reporting and Documentation
We provide:
- Complete impurity profile
- Structure confirmation (if needed)
- Validation reports
- Regulatory-ready documentation for submission
Real Case Study: FDA-Compliant Related Substances Analysis for an Antibiotic
Client: US-based generic drug manufacturer
Objective: Perform related substances testing for ANDA submission of a generic cephalosporin
Testing Tools:
- HPLC with UV detection
- LC-MS/MS for unknown impurity identification
- NMR for structure confirmation
Outcome:
- Identified and quantified 7 related substances
- One new impurity structurally confirmed via 1H-NMR and MS
- Accepted by FDA with no data deficiencies
This project shows our strength in impurity testing with clear, validated results.
How ResolveMass Helps You Stay Compliant
ResolveMass Laboratories offers complete analytical packages:
- Impurity method development
- Validation as per ICH/FDA
- Stability studies
- Batch-to-batch comparison
We support pharmaceutical developers in Montreal, across the US, and globally with:
- GMP-certified lab
- Fast turnaround (2–4 weeks)
- Regulatory guidance from start to submission
📍 We specialize in Related Substances Analysis in United States and across Canada.
Conclusion
Related substances analysis is essential for regulatory success. It proves your drug is pure, stable, and safe for patients. At ResolveMass Laboratories, we provide FDA-compliant, ICH-aligned services for impurity profiling using world-class instruments. Whether you’re based in Canada or looking for Related Substances Analysis in United States, we’re here to support your submission from early development to final filing.
✅ Start your impurity study with ResolveMass
✅ Talk to an expert
✅ Book a consultation today
The Role of Extractables and Leachables (E&L) in Carcinogenicity Risk
Introduction Extractables and Leachables Carcinogenicity Testing plays a vital role in protecting patients who rely…
Case Study: Forced Degradation Study of Gimeracil — Discovery and Structure Elucidation of Novel Impurities
Introduction Forced degradation studies are a cornerstone of modern pharmaceutical development, enabling scientists to intentionally…
Affordable Bioanalytical Services for Start-Up Biotech: What to Expect
INTRODUCTION Affordable bioanalytical services for start-up biotech companies provide the essential analytical support needed to…
Top Bioanalytical Services for Small & Large Molecule Quantification
Introduction Bioanalytical services for small & large molecule quantification are essential for ensuring precision, sensitivity,…
Why Choose ResolveMass Laboratories for Bioanalytical Services: A Service Overview
INTRODUCTION The short answer is: clients choose ResolveMass because this ResolveMass Bioanalytical Services Overview demonstrates…
Case Study: Forced Degradation and Impurity Profiling of Nelarabine — Structural Elucidation of Novel Degradation Products
Introduction: The Critical Role of Forced Degradation in Defining Nelarabine Stability Forced degradation testing continues…

